Kidney protection drug tested in large chinese study
NCT ID NCT06610526
Summary
This study aims to understand how well the medication dapagliflozin works and how safe it is for Chinese adults with chronic kidney disease. It involves 731 participants who will take the drug to see if it can slow the worsening of their kidney function. The research focuses on measuring changes in kidney health markers and tracking serious health events over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Beijing, 100034, China
-
Research Site
Beijing, 100044, China
-
Research Site
Beijing, 100068, China
-
Research Site
Beijing, 100191, China
-
Research Site
Beijing, 102206, China
-
Research Site
Changchun, 130021, China
-
Research Site
Dongguan, 523059, China
-
Research Site
Foshan, 528308, China
-
Research Site
Fuyang, 236012, China
-
Research Site
Fuzhou, 350001, China
-
Research Site
Ganzhou, 341099, China
-
Research Site
Harbin, 150000, China
-
Research Site
Hefei, 230601, China
-
Research Site
Hengyang, 421001, China
-
Research Site
Huaian, 223399, China
-
Research Site
Huizhou, 516001, China
-
Research Site
Jilin, 132011, China
-
Research Site
Jinan, 250014, China
-
Research Site
Jining, 272029, China
-
Research Site
Lanzhou, 730000, China
-
Research Site
Linyi, 276199, China
-
Research Site
Nanchang, 330006, China
-
Research Site
Nanjing, 210029, China
-
Research Site
Nanning, 530021, China
-
Research Site
Ningbo, 315010, China
-
Research Site
Shanghai, 200090, China
-
Research Site
Shenzhen, 518036, China
-
Research Site
Suzhou, 215004, China
-
Research Site
Taian, 271099, China
-
Research Site
Tianjin, 300121, China
-
Research Site
Wuhu, 241000, China
-
Research Site
Wuxi, 214023, China
-
Research Site
Xi'an, 710000, China
-
Research Site
Xiamen, 361004, China
Conditions
Explore the condition pages connected to this study.